Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

被引:8
|
作者
Mitsuteru Kitade [1 ]
Hitoshi Yoshiji [1 ]
Ryuichi Noguchi [1 ]
Yasuhide Ikenaka [1 ]
Kosuke Kaji [1 ]
Yusaku Shirai [1 ]
Masaharu Yamazaki [1 ]
Masahito Uemura [1 ]
Junichi Yamao [1 ]
Masao Fujimoto [1 ]
Akira Mitoro [1 ]
Masahisa Toyohara [1 ]
Masayoshi Sawai [1 ]
Motoyuki Yoshida [1 ]
Chie Morioka [1 ]
Tatsuhiro Tsujimoto [1 ]
Hideto Kawaratani [1 ]
Hiroshi Fukui [1 ]
机构
[1] Third Department of Internal Medicine, Nara Medical University
关键词
Angiogenesis; Cytokeratin-18; Fatty liver; Insulin resistance; Non-alcoholic steatohepatitis; Liver fi brosis;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
1002 ; 100201 ;
摘要
AIM: To elucidate the possible crosstalk between angiogenesis, cytokeratin-18 (CK-18), and insulin resistance (IR) especially in patients with non-alcoholic steatohepatitis (NASH).METHODS: Twenty-eight patients with NASH and 11 with simple fatty liver disease (FL) were enrolled in this study and underwent clinicopathological examination. The measures of angiogenesis, CK-18, and IR employed were CD34-immunopositive vessels, CK-18immunopositive cells, and homeostasis model assessment of IR (HOMA-IR), respectively. The correlations of these factors with NASH were elucidated.RESULTS: Significant development of hepatic neovascularization was observed only in NASH, whereas almost no neovascularization could be observed in FL and healthy liver. The degree of angiogenesis was almost parallel to liver fibrosis development, and both parameters were positively correlated. Similarly, CK-18expression and HOMA-R were signifi cantly increased in NASH as compared with FL and healthy liver. Furthermore, CK-18 and HOMA-IR were also positively correlated with the degree of neovascularization. CONCLUSION: These results indicate that the crosstalk between angiogenesis, CK-18, and IR may play an important role in the onset and progression of NASH.
引用
下载
收藏
页码:5193 / 5199
页数:7
相关论文
共 50 条
  • [41] TOLL LIKE RECEPTOR MEDIATED CELLULAR CROSSTALK IN ALCOHOLIC AND NON-ALCOHOLIC STEATOHEPATITIS
    Seki, E.
    Brenner, D. A.
    Tsukamoto, H.
    Inokuchi, S.
    Miura, K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 21A - 21A
  • [42] Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
    Luyckx, FH
    Lefebvre, PJ
    Scheen, AJ
    DIABETES & METABOLISM, 2000, 26 (02) : 98 - 106
  • [43] Key molecular pathways in the progression of non-alcoholic steatohepatitis
    Tong, J.
    Guo, J-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (19) : 8515 - 8522
  • [44] The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis
    Lee, Su Jin
    Do Yoo, Jae
    Choi, Soo Young
    Kwon, Oh-Shin
    BMB REPORTS, 2014, 47 (08) : 457 - 462
  • [45] Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis
    Kitade, Mitsuteru
    Yoshiji, Hitoshi
    Kojima, Hideyuki
    Ikenaka, Yasuhide
    Noguchi, Ryuichi
    Kaji, Kosuke
    Yoshii, Junichi
    Yanase, Koji
    Namisaki, Tadashi
    Yamazaki, Masaharu
    Tsujimoto, Tatsuhiro
    Moriya, Kei
    Kawaratani, Hideto
    Akahane, Takemi
    Fukui, Hiroshi
    MOLECULAR MEDICINE REPORTS, 2008, 1 (04) : 543 - 548
  • [46] Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
    Marra, Fabio
    Gastaldelli, Arnalia
    Baroni, Gianluca Svegliati
    Tel, Gianluca
    Tiribelli, Claudio
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (02) : 72 - 81
  • [47] Combined measurement of serum fragmented cytokeratin 18 and ferritin improved diagnostic accuracy of non-alcoholic steatohepatitis
    Kim, Young Seok
    Jung, Eun Sun
    Yoon, Seung Kew
    Bae, Si Hyun
    Choi, Jong Young
    Song, Myeong Jun
    Kim, Chang Wook
    Cho, Se Hyun
    Lee, Chang Don
    Lee, Young Sok
    Choi, Sang Wook
    Yang, Jin Mo
    Jang, Jeong Won
    Kim, Sang Gyune
    Jeong, Soung Won
    Kim, Hee Kyung
    Hur, Wonhee
    HEPATOLOGY, 2012, 56 : 896A - 897A
  • [48] CAN DISEASE PROGRESSION IN NON-ALCOHOLIC STEATOHEPATITIS BE STOPPED?
    Copaci, I.
    Mindrut, E.
    Micu, L.
    Hortopan, M.
    Voiculescu, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S358 - S358
  • [49] Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
    Ramai, Daryl
    Tai, Waqqas
    Rivera, Michelle
    Facciorusso, Antonio
    Tartaglia, Nicola
    Pacilli, Mario
    Ambrosi, Antonio
    Cotsoglou, Christian
    Sacco, Rodolfo
    BIOMEDICINES, 2021, 9 (02) : 1 - 17
  • [50] Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis
    Ghandian, Sina
    Thapa, Rahul
    Garikipati, Anurag
    Barnes, Gina
    Green-Saxena, Abigail
    Calvert, Jacob
    Mao, Qingqing
    Das, Ritankar
    JGH OPEN, 2022, 6 (03): : 196 - 204